comprehensive -WSS

comprehensive

author：entertainment 2025-09-30 00:02:35 - browse：628

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Heart disease in astronauts blamed on cosmic radiation

leisure time

WSS

Hospital chaplains balance Covid safety with patients’ spiritual needs

Medicare Advantage coverage denials need scrutiny, senators say

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

H.R. 3 is the wrong path to lower drug costs

Medicare slashes safety net hospital payments by nearly $1 billion

Life science postdocs should get big pay hike, NIH panel says

focus

comprehensive

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

JPM pitch from hospitals? Revenue streams outside of patient care

Bright Health sells Medicare Advantage business to Molina

Arena BioWorks launches in Cambridge to speed drug discovery

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How to ethically and practically extend health care to all

Medical leaders decry Supreme Court decision on affirmative action

Physicians aren't 'burning out.' They're suffering from moral injury

hotspot

Study links childhood stress with decline in older age

CDC recommends RSV monoclonal antibody for infants

Study suggests new cause of Down syndrome: cells linked to aging

FDA scientists endorse Pfizer/BioNTech Covid

FDA approves Sage Therapeutics’ rapid

Flint parents haunted by uncertainty, fears of lead poisoning

entertainment

leisure time

entertainment

hotspot